Skip to main content
. Author manuscript; available in PMC: 2008 Nov 10.
Published in final edited form as: Gut. 2008 Jun;57(6):756–763. doi: 10.1136/gut.2007.142810

Table 6.

Abdominal bloating sites in different FGIDs. Results are given as odds ratios* (95% CI)

Upper site vs general abdomen Lower site vs general abdomen Lower site vs upper site
Female 0.5 (0.3 to 0.7) 2.1 (1.4 to 3.4) 4.6 (2.9 to 7.4)
IBS 0.7 (0.3 to 1.4) 2.1 (1.1 to 4.0) 3.2 (1.5 to 6.8)
Dyspepsia 5.8 (1.5 to 22.4) 1.5 (0.3 to 7.8) 0.3 (0.1 to 1.03)
FC 0.8 (0.3 to 1.9) 2.6 (1.3 to 5.4) 3.3 (1.4 to 7.7)
GORD 1.2 (0.6 to 2.3) 1.3 (0.7 to 2.6) 1.1 (0.5 to 2.3)
GI complex overlap 0.9 (0.5 to 1.7) 0.6 (0.4 to 1.1) 0.7 (0.4 to 1.3)
*

Multiple variable logistic models adjusted for age and SSC score.

IBS, dyspepsia, FC and GORD were cases with no GI complex symptom overlap.

GI complex overlap: subjects can be defined as more than one of the above disorders.

FC, functional constipation; FGIDs, functional gastro-intestinal disorders; GI, gastro-intestinal; GORD, gastro-oesophageal reflux disease; IBS, irritable bowel syndrome; SSC, Somatic Symptom Checklist.